The transcript encoding endonuclein, the human homolog of yeast PWP1, was previously found up-regulated in pancreatic cancer tissue. By immunohistochemistry we detected a ubiquitous presence in several tissues examined: skin, liver, thyroid gland, heart muscle, neurons, kidney, bladder, pancreas, adrenal gland, ovary, uterus, testis and prostate gland. We especially noticed that normal pancreatic exocrine cells exhibited low protein levels while pancreatic adenocarcinoma cells revealed high levels. We found a heterogeneous subcellular distribution, especially with varying nuclear levels. In proliferating cells endonuclein protein expression and localization was cell cycle dependent, with increasing levels and nuclear focusing during the interphase toward mitosis. Ultrastructural analysis revealed ER and nuclear localization. Endonuclein contains ®ve WD-repeats, indicating a putative role in crucial regulatory activities in the nucleus as well as in the ER.
The transcript encoding endonuclein, the human homolog of yeast PWP1, was previously found up-regulated in pancreatic cancer tissue. By immunohistochemistry we detected a ubiquitous presence in several tissues examined: skin, liver, thyroid gland, heart muscle, neurons, kidney, bladder, pancreas, adrenal gland, ovary, uterus, testis and prostate gland. We especially noticed that normal pancreatic exocrine cells exhibited low protein levels while pancreatic adenocarcinoma cells revealed high levels. We found a heterogeneous subcellular distribution, especially with varying nuclear levels. In proliferating cells endonuclein protein expression and localization was cell cycle dependent, with increasing levels and nuclear focusing during the interphase toward mitosis. Ultrastructural analysis revealed ER and nuclear localization. Endonuclein contains ®ve WD-repeats, indicating a putative role in crucial regulatory activities in the nucleus as well as in the ER. Oncogene (2002) 21, 1123 ± 1129. DOI: 10.1038/sj/onc/ 1205186
Keywords: cell cycle regulated protein; nucleus, endoplasmic reticulum; signal transduction; chaperone activity Pancreatic cancer is the fourth most common cause of cancer death in western society. The 5-year survival rate is approximately 1 ± 2%, characterizing the tumor as one of the most aggressive. The incidence rate is increasing and the treatment is ineective with a poor prognosis (Myers and Ries, 1989; Murr et al., 1994) . The molecular biology of pancreatic cancer is not well understood. Some cases of mutations in certain genes or changes in the level of expression of the genes have been described, e.g., the ras oncogene (Bos, 1989) , p53 (Simon et al., 1994) , MTS1 , DPC4 (Hahn et al., 1996) , epidermal growth factor and epidermal growth factor receptor (Korc et al., 1992) , cyclin D1 (Kornmann et al., 1998), p16 INK4 (Naka et al., 1998) , as well as insulin-like growth factor-1 receptor, stat3 and the tyrosine kinase src (Coppola, 2000) . Several other genes may be involved in the primary and secondary processes that are responsible for the development of the phenotype of pancreatic cancer cells. In a recent study, using a dierential screening technique, the transcripts of about 400 proteins were found to be up-regulated in pancreatic cancer tissue compared with normal tissue (Gress et al., 1996) . One of the transcripts encode the human homolog, hPWP1, of the yeast periodic tryptophan protein 1, PWP1 (Duronio et al., 1992) cloned in our laboratory some years ago (HonoreÂ et al., 1994) . The protein may thus be a putative disease-associated marker or a putative oncogene (Gress et al., 1996) in line with the fact that yeast PWP1 null mutants grow slowly (Duronio et al., 1992) . However, it is essential to establish whether the up-regulation of the transcript is followed by up-regulation of the protein in pancreatic cancer. In the latter case the protein, which we suggest be named endonuclein, may then participate in the development of the phenotype of pancreatic cancer cells.
The primary structure of endonuclein reveals several repeats of about 40 amino acids in length containing a Trp ± Asp (WD) dipeptide, that has been given various names, the b-transducin repeat (Duronio et al., 1992) , the WD-40 repeat (Fong et al., 1986; van der Voorn and Ploegh, 1992) , the GH ± WD-repeat (Neer et al., 1993) or the WD-repeat Smith et al., 1999) . The three-dimensional structure of the WDrepeat is known from the Gb subunit of the G proteins, which has revealed a correspondence between the sequence repeat and the structural repeat, implying that all proteins with this motif belong to the same structural class. The proteins consist of 4 ± 16 WDrepeats forming an up to eight blade propeller structure that creates a stable platform that may form complexes reversibly with several proteins (Smith et al., 1999) . With a few exceptions this motif has so far only been found in eukaryotes, with the identi®cation of about 150 proteins (Smith et al., 1999) . Although the proteins are structurally very similar, the group is functionally diversi®ed, with all members seemingly possessing regulatory functions rather than enzymatic . To date, the function of various protein members have thus been ascribed to crucial regulatory roles in signal transduction, RNA processing, gene expression, tracking of vesicles, assembly of cytoskeletal components, as well as participation in the regulation of the cell cycle .
In order to learn more about the functional role of endonuclein we ®rst studied the subcellular localization in greater detail. The protein contains a putative nuclear localization signal (NLS) and we have previously con®rmed the presence of the protein in the nucleus, suggesting that the NLS is functional (HonoreÂ et al., 1994 ). An antibody was raised against the recombinant protein ( Figure 1A ), anity puri®ed and tested to be speci®c by Western blotting ( Figure  1B) . The anti-endonuclein antibody recognizes a single band between 65 and 89 kDa at a position similarly to the position of the recombinant protein ( Figure 1A ). The anti-endonuclein was used for immuno¯uorescence detection of endonuclein in unsynchronized HaCaT cells ( Figure 1C ). The nuclei of the cells were counterstained with DAPI ( Figure 1D ). The anti-endonuclein antibody stained the cells in a highly heterogeneous manner, which was apparent both in the level of expression as well as in the localization ( Figure 1C ). The endonuclein expression levels vary from below detection level (see cell marked`a' in Figure 1C ) over a faint labeling in the cytoplasm (cells marked`b' and`c' in Figure 1C ) to a strong labeling in the cytoplasm together with a faint labeling in the nucleus (cell marked`d' in Figure 1C ). Other cells showed a strong labeling in the nucleus and a faint labeling in the cytoplasm (cell marked`e' in Figure 1C ) while ®nally et al., 1994) was PCR ampli®ed essentially as previously described (HonoreÂ et al., 1995) , cut with the appropriate enzymes and ®nally ligated into the expression vector pT7-PL giving a fusion protein that was synthesized with MGSHHHHHHGSIEGR in the NH 2 -terminal (pT7-PL-2309.2). The protein was expressed and puri®ed from E. coli cells essentially as previously described in detail (Vorum et al., 1998) . (B) An anity puri®ed, polyclonal antibody (anti-endonuclein) was made and tested on MRC-5 cells by Western blotting essentially as previously described . (C) Unsynchronized HaCaT cells were grown on coverslips, formaldehyde ®xed and analysed by indirect immuno¯uorescence using TRITC-conjugated swine anti-rabbit IgG (R156, DAKO, Glostrup, Denmark) as described . 4,6-diamidino-2-phenylindole (DAPI), used for counterstaining of nuclei, was from Sigma Immuno Chemicals (St. Louis, MO, USA). Observations were made on a photomicroscope equipped with epi¯uorescence (Olympus). (D) DAPI staining of the nuclei. (E) and (G) Mitotic cells reacted with anti-endonuclein, and (F) and (H) corresponding DAPI staining some cells exhibited a very strong labeling in the nucleus with a nearly undetectable level in the cytoplasm (cells marked`f' and`g' in Figure 1C ). The corresponding DAPI staining of the nuclei indicates that the levels of expression of endonuclein, as well as the subcellular localization of the protein, depends upon where the particular cell is in the cell cycle, at least in cultured cells. The immuno¯uores-cence studies of the unsynchronized cells thus indicated that cells that stain weakly with DAPI, i.e. cells that are in G 1 phase or early S phase, have low levels of endonuclein, mainly in the cytoplasm, while cells that stain stronger with DAPI, i.e. cells that are in late S phase or G 2 phase of the cell cycle have higher amounts of endonuclein, mainly localized in the nuclei (cells marked`f' and`g' in Figure 1C ). Mitotic cells are easily distinguished from interphase cells due to the staining of the individual chromosomes with DAPI ( Figure 1F ,H) and they were found to possess high amounts of endonuclein ( Figure 1E,G) .
We then set forward studies to verify the assumption that the level of endonuclein depends upon the phase of the cell cycle. For that purpose we chose to use transformed human amnion cells, since these cells can easily be synchronized with the mitotic detachment technique thereby avoiding the use of chemicals that itself may induce changes in the cells. Cells were harvested with intervals of 2 h from onset of mitosis. In order to check the synchronization of the cells and to monitor the quality of the synchronization method some of the cells were in vivo labeled with BrdU before harvesting to determine the number of cells in S phase. As seen in the three upper panels in Figure 2 , only very few cells are in S phase 2 h after mitotic detachment. From about 6 h the number of S phase cells increases steadily as the cell cycle progresses. The number is at maximum about 10 h after mitosis where 93% of the cells are in S phase. From 10 h and on the number of S phase cells decreases as the cells enter G 2 phase. The duration of the G 2 phase is only a few hours as seen from the number of mitotic cells that are apparent around 14 ± 16 h (Figure 2, panel 4) . Measuring the amount of total protein in the cells also reveals this. The protein content of the cells, measured as described in Figure 2 , thus increases from about 2.5 mg/ml to about 5 mg/ml in agreement with doubling of the number of cells just around 12 ± 16 h (Figure 2, panel 5 ). The number of S Figure 2 Expression of endonuclein is synchronized transformed amnion cells (AMA). Transformed amnion cells were synchronized by using the mitotic detachment technique . A stock solution of suspended mitotic cells was prepared from six 250 ml culture¯asks of sub-con¯uent AMA cells. Three ml aliquots were plated in 3 cm Petri dishes. The cells were harvested with 2 h time intervals with a police rubberman and saved in Eppendorf tubes. Cells were pelleted and resuspended in 100 ml PBS. Aliquots were used for 1-D Western blotting and determination of protein concentration by the Bradford technique (BioRad) (Bradford, 1976) . A parallel series of Petri dishes contained coverslips. At each cell harvesting a coverslip was used for detection of the amount of cells in S phase by labeling with 5-bromo-2'-deoxy-uridine (BrdU) beginning 30 min prior to harvesting, followed by ®xation in 70% ethanol, 50 mM glycine buer, pH 2. (Figure 2, panel 6) shows that the cells exhibit very low levels just after mitosis. As the number of S phase cells increases (2 ± 10 h) the level of endonuclein rises markedly. When the number of S phase cells again decreases (10 ± 18 h) and the cells enter G 2 phase and mitosis the level of endonuclein also decreases. Endonuclein thus accumulates in the cell especially during S phase suggesting a cell cycle regulated expression as basis for the heterogeneous type of immuno¯uorescence labeling of the cells shown in Figure 1 . From the cell synchronization study shown in Figure 2 it cannot be ®rmly concluded in which particular phase of the cell cycle, G 2 phase, mitosis or early G 1 phase the endonuclein level starts to decrease due to the short duration of the G 2 phase and the mitotic phase. However, the immuno¯uorescence studies, Figure 1 , clearly indicated that cells that had gone into mitosis stain strongly with anti-endonuclein ( Figure 1E,G) suggesting that the level of endonuclein does not decrease markedly until the late mitotic phase or early G 1 phase. Thus, in cultured cells the endonuclein level is dependent upon the cell cycle with levels that increase steadily as the cell passes through G 1 , S, and G 2 phase until mitosis after which the level decreases in late mitosis or early G 1 phase. The immuno¯uorescence studies in Figure 1 also suggested that the subcellular localization of endonuclein is dependent upon the cell cycle.
Next we performed ultrastructural studies in order to de®ne in which subcellular localization endonuclein could be found. Immunoelectron microscopy was performed on cultured transformed human MRC-5 ®broblasts, MRC-5 V2 ( Figure 3A ± C) . The labeled cells showed a strong heterogeneity con®rming the immuno¯uorescence analysis reported in Figure 1 . Some of the cells revealed a quite strong labeling in the nucleus (Figure 3A,B) . The label was mainly found in the nucleolus ( Figure 3A ) and in the euchromatic parts of the nucleoplasm (Figure 3B ), i.e. locations where the DNA is actively transcribed into RNA. The entrance of endonuclein into the nucleus is in agreement with the presence of a nuclear localization signal (NLS). The labeling in the cytoplasm was at low level and when found it was localized in the endoplasmic reticulum (ER) as indicated with arrows in Figure 3C . The ER localization was further con®rmed by using confocal laser-scanning microscopy. Cultured HaCaT cells were labeled with anti- Figure 3 Ultrathin cryosections (40 ± 60 nm) of MRC-5 V2 cells labeled with anti-endonuclein and visualized with gold-anti-rabbit IgG conjugated to 10-nm gold particles performed on MRC-5 V2 cells as previously described . Endonuclein is a cell cycle regulated protein B Honore Â et al endonuclein together with an antibody recognizing a speci®c 43 kDa cytoplasmic antigen of the rough endoplasmic reticulum, RER. Some of the cells were labeled in the nuclei as well as in the cytoplasm with anti-endonuclein (red¯uorescence, Figure 3D ). The antibody recognizing the 43 kDa component of the RER labels the ER green around the nuclei as expected ( Figure 3E ). Superposition of these two images con®rmed that cytoplasmic localized endonuclein indeed was localized in the ER (yellow¯uorescence in Figure 3F ). It is unknown by which mechanism endonuclein enters through the membrane into the ER since the primary structure of the protein does not contain an N-terminal signal sequence. A possibility might be the use of an ATP binding cassette (ABC) translocator localized in the ER membrane. At least in case of secretion of interleukin-1b, that belongs to the family of leaderless secretory proteins released from the Figure 4 Immunoperoxidase staining of various normal and pathological human tissues with anti-endonuclein. Normal tissue and tumor tissue from pancreas was obtained during operation. Other tissues were obtained from autopsy. The tissues were formalin ®xed, embedded in paran and used for light microscopic evaluation after staining with anti-endonuclein antibody using horseradish peroxidase labeled secondary antibody as previously described in detail . (A) keratinocytes; (B) liver; (C) nervous tissue; (D) thyroid gland; (E) heart muscle; (F) islets of Langerhans; (G) normal exocrine pancreatic tissue; (H) adenocarcinoma of the exocrine pancreas. Endonuclein is a ubiquitous protein expressed in various tissues with a heterogeneous distribution between the cytoplasm and the nucleus. In the tissues examined nuclear staining varied from below detection limit (white arrowheads) to above the amounts found in the cytoplasm (black arrowheads). Especially in the normal exocrine pancreatic tissue we found very low levels while the tissue from ductal adenocarcinoma of the pancreas stained strongly with anti-endonuclein antibody cell by a non-classical secretory route, it has been shown that the ABC1 translocator is involved in the secretion (Hamon et al., 1997) . Also, in case of secretion of another leaderless protein, annexin 1, there is evidence that annexin 1 is translocated to the plasma membrane although the molecular mechanism is still unknown (Christmas et al., 1991; Kang et al., 1996) . In order to reveal whether the heterogeneous localization is restricted to proliferating cells or whether it is a general phenomenon also in nonproliferating cells we undertook an examination of several normal and pathological human tissues that were immunoperoxidase stained for endonuclein. Figure 4 shows immunoperoxidase staining of a variety of human tissues. As is apparent the cellular staining pattern is heterogeneous. The nuclei of some cells do not stain or stain very weakly with the antiendonuclein antibody. The nuclei of these cells appear blue due to staining with hematoxylin (some of these cells are indicated with white arrowheads in Figure 4 ). The nuclei of other cells stain quite strongly with antiendonuclein antibody as seen by the brown colored nuclei as indicated with black arrowheads in Figure 4 . Thus, also in cells in vivo we ®nd a dierential distribution of endonuclein between the nucleus and the cytoplasm among various cells. Apparently, the dierential localization does not imply that cells are proliferating, since only the basal keratinocyte layer possesses mitotic cells whereas more super®cially localized cells are in a post mitotic phase ( Figure  4A ). We found that the endonuclein protein is ubiquitously expressed, here detected in skin, liver, neurons, thyroid gland, heart muscle, kidney, bladder, pancreas, adrenal gland, ovary, uterus, testis and prostate gland. In pancreas, the islets of Langerhans exhibited a moderate degree of staining ( Figure 4F ) while very low levels were detected in the normal exocrine acinar cells ( Figure 4G ). In contrast, the levels found in ductal adenocarcinoma cells, as detected by immunoperoxidase staining, were high ( Figure 4H ) in agreement with the up-regulation of the endonuclein transcript in pancreatic cancer previously observed (Gress et al., 1996) indicating that endonuclein may participate in the development of the phenotype of pancreatic cancer cells.
Several WD-repeat proteins are known to form multiprotein complexes by interacting with other proteins sometimes through their WD-repeat domains. Identi®cation of interacting proteins may thus contribute to further reveal the functions of novel WDrepeat proteins. We have recently puri®ed several endonuclein interacting proteins (manuscript in preparation). The type of some of these proteins; a transcription factor, a viral oncogene binder and proteins belonging to the molecular chaperones con®rms a regulatory role for endonuclein, especially with respect to modulation of signal transduction pathways to the nucleus and chaperone activities in the ER. The speci®c function(s) of endonuclein in these processes will be the focus of future studies.
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